{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:55:42Z","timestamp":1766393742238,"version":"3.48.0"},"reference-count":27,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"cultural office of the city of Graz"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Introduction: Postpartum hemorrhage remains a leading cause of maternal morbidity and mortality worldwide. While antifibrinolytic agents such as tranexamic acid are effective in treating established postpartum hemorrhage, the benefit of prophylactic tranexamic acid remains debated. The presence and frequency of early postpartum hyperfibrinolysis during routine childbirth have not been thoroughly investigated. Material &amp; Methods: This prospective observational study was registered on ClinicalTrials.gov (NCT05975112) and conducted at the Medical University Hospital Graz between June 2023 and June 2024. Blood samples were collected from 413 women immediately after umbilical cord clamping; 379 were included in the analysis\u2014291 undergoing Caesarean section and 88 vaginal delivery. Hyperfibrinolysis was assessed using thromboelastography and defined as an LY30 value &gt; 8%. Additional coagulation parameters\u2014including fibrinogen, D-dimer, activated partial thromboplastin time, and prothrombin time\u2014were measured. Correlation analyses between viscoelastic and conventional parameters were performed using Pearson\u2019s correlation coefficients. Results: No cases of clinically significant hyperfibrinolysis (LY30 &gt; 8%) were observed. However, 15.5% of women showed elevated LY30 values (&gt;0%). LY30 values were significantly higher in vaginal deliveries compared to Caesarean sections (p = 0.003). A moderate correlation between maximum amplitude (MA) and fibrinogen was observed (r = 0.52), strongest in vaginal deliveries (r = 0.65). Other correlations were weak or negligible. Conclusions: Clinically relevant hyperfibrinolysis was not observed immediately postpartum in women without hemorrhage. These findings are consistent with current guidelines recommending tranexamic acid for therapeutic rather than routine prophylactic use. Viscoelastic testing may be useful for rapid assessment in early-stage bleeding. Further research should explore fibrinolytic activity later in the postpartum period.<\/jats:p>","DOI":"10.3390\/jcm15010027","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:35:27Z","timestamp":1766392527000},"page":"27","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperfibrinolysis During Caesarean Section and Vaginal Delivery: A Prospective Cross-Sectional Study in the Delivery Room"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7643-3193","authenticated-orcid":false,"given":"Philipp","family":"Zoidl","sequence":"first","affiliation":[{"name":"Division of Anaesthesiology and Intensive Care Medicine 1, Department of Anaesthesiology and Intensive Care, Medical University of Graz, Auenbruggerplatz 5, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9006-075X","authenticated-orcid":false,"given":"Gabriel","family":"Honnef","sequence":"additional","affiliation":[{"name":"Division of Anaesthesiology and Intensive Care Medicine 1, Department of Anaesthesiology and Intensive Care, Medical University of Graz, Auenbruggerplatz 5, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8510-1123","authenticated-orcid":false,"given":"Michael","family":"Eichinger","sequence":"additional","affiliation":[{"name":"Division of Anaesthesiology and Intensive Care Medicine 1, Department of Anaesthesiology and Intensive Care, Medical University of Graz, Auenbruggerplatz 5, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6307-8388","authenticated-orcid":false,"given":"Michael","family":"Eichlseder","sequence":"additional","affiliation":[{"name":"Division of Anaesthesiology and Intensive Care Medicine 1, Department of Anaesthesiology and Intensive Care, Medical University of Graz, Auenbruggerplatz 5, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7510-3330","authenticated-orcid":false,"given":"Lioba","family":"Heuschneider","sequence":"additional","affiliation":[{"name":"Division of Anaesthesiology and Intensive Care Medicine 1, Department of Anaesthesiology and Intensive Care, Medical University of Graz, Auenbruggerplatz 5, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4062-2572","authenticated-orcid":false,"given":"Sascha","family":"Hammer","sequence":"additional","affiliation":[{"name":"Division of Anaesthesiology and Intensive Care Medicine 1, Department of Anaesthesiology and Intensive Care, Medical University of Graz, Auenbruggerplatz 5, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3691-8457","authenticated-orcid":false,"given":"Nikolaus","family":"Schreiber","sequence":"additional","affiliation":[{"name":"Division of Anaesthesiology and Intensive Care Medicine 2, Department of Anaesthesiology and Intensive Care, Medical University of Graz, Auenbruggerplatz 5, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3388-0089","authenticated-orcid":false,"given":"Florian","family":"Pr\u00fcller","sequence":"additional","affiliation":[{"name":"Clinical Institute for Medical and Chemical Laboratory Diagnostics (KIMCL), University Hospital Graz, Auenbruggerplatz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva Christine","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical University of Graz, Auenbruggerplatz 14, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Amtmann","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical University of Graz, Auenbruggerplatz 14, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-3752","authenticated-orcid":false,"given":"Helmar","family":"Bornemann-Cimenti","sequence":"additional","affiliation":[{"name":"Division of Anaesthesiology and Intensive Care Medicine 1, Department of Anaesthesiology and Intensive Care, Medical University of Graz, Auenbruggerplatz 5, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Gruneberg, D., Braun, P., Sch\u00f6chl, H., Nachtigall-Schmitt, T., von der Forst, M., Tourelle, K., Dietrich, M., Wallwiener, M., Wallwiener, S., and Weigand, M.A. (2023). Fibrinolytic potential as a risk factor for postpartum hemorrhage. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1208103"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"Collaborators","year":"2017","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1056\/NEJMra1513247","article-title":"Postpartum Hemorrhage","volume":"384","author":"Bienstock","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_4","unstructured":"World Health Organization (2023). A Roadmap to Combat Postpartum Haemorrhage Between 2023 and 2030, World Health Organization."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1471-0528.12636","article-title":"on behalf of the WHO Multicountry Survey on Maternal and Newborn Health Research Network. Postpartum haemorrhage management, risks, and maternal outcomes: Findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health","volume":"121","author":"Sheldon","year":"2014","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Li, S., Gao, J., Liu, J., Hu, J., Chen, X., He, J., Tang, Y., Liu, X., Cao, Y., and Liu, X. (2021). Incidence and Risk Factors of Postpartum Hemorrhage in China: A Multicenter Retrospective Study. Front. Med., 8.","DOI":"10.3389\/fmed.2021.673500"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/AOG.0000000000004972","article-title":"Postpartum Hemorrhage Trends and Outcomes in the United States, 2000\u20132019","volume":"141","author":"Friedman","year":"2023","journal-title":"Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S1701-2163(16)34984-2","article-title":"Risk Factors for Postpartum Hemorrhage: Can We Explain the Recent Temporal Increase?","volume":"33","author":"Kramer","year":"2011","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_9","unstructured":"DGGG (2025, November 15). S2k-Leitlinie Peripartale Blutungen, Diagnostik und Therapie. Available online: https:\/\/register.awmf.org\/de\/leitlinien\/detail\/015-063."},{"key":"ref_10","first-page":"CD011689","article-title":"Uterotonic agents for preventing postpartum haemorrhage: A network meta-analysis","volume":"4","author":"Gallos","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_11","first-page":"Qc17","article-title":"Role of Prophylactic Tranexamic Acid in Reducing Blood Loss during Elective Caesarean Section: A Randomized Controlled Study","volume":"10","author":"Lakshmi","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1800942","article-title":"Tranexamic Acid for the Prevention of Blood Loss after Vaginal Delivery","volume":"379","author":"Sentilhes","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJMoa2028788","article-title":"Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery","volume":"384","author":"Sentilhes","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-0030-1255745","article-title":"Verfahren zur Messung der Thrombozytenfunktion: Pro und kontra","volume":"6","author":"Herkommer","year":"2010","journal-title":"Kardiol. Up2date"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijoa.2013.07.003","article-title":"Major obstetric haemorrhage: Monitoring with thromboelastography, laboratory analyses or both?","volume":"23","author":"Karlsson","year":"2014","journal-title":"Int. J. Obstet. Anesth."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/aogs.12607","article-title":"Hemostatic resuscitation in postpartum hemorrhage\u2014A supplement to surgery","volume":"94","author":"Ekelund","year":"2015","journal-title":"Acta Obstet. Et Gynecol. Scand."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1177\/0310057X1204000612","article-title":"Point-of-Care Testing of Coagulation and Fibrinolytic Status during Postpartum Haemorrhage: Developing a Thrombelastography\u00ae-Guided Transfusion Algorithm","volume":"40","author":"Hill","year":"2012","journal-title":"Anaesth. Intensive Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ajh.23599","article-title":"TEG and ROTEM: Technology and clinical applications","volume":"89","author":"Whiting","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"370","author":"Altman","year":"2007","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1213\/ANE.0000000000004796","article-title":"Thromboelastographic Assessment of Fibrinolytic Activity in Postpartum Hemorrhage: A Retrospective Single-Center Observational Study","volume":"131","author":"Arnolds","year":"2020","journal-title":"Anesth. Analg."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Roberts, I., Shakur, H., Fawole, B., Kuti, M., Olayemi, O., Bello, A., Ogunbode, O., Kotila, T., Aimakhu, C.O., and Olutogun, T. (2018). Haematological and fibrinolytic status of Nigerian women with post-partum haemorrhage. BMC Pregnancy Childbirth, 18.","DOI":"10.1186\/s12884-018-1794-1"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ajh.2830190407","article-title":"Neonatal and maternal fibrinolysis: Activation at time of birth","volume":"19","author":"Suarez","year":"1985","journal-title":"Am. J. Hematol."},{"key":"ref_23","unstructured":"Schmolzer, G. (2019). Hemostasis for Massive Hemorrhage during Cesarean Section. Recent Advances in Cesarean Delivery, IntechOpen."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1521-6926(03)00021-5","article-title":"Haemostatic changes in pregnancy","volume":"16","author":"Bremme","year":"2003","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/jth.14882","article-title":"Systematic review of viscoelastic testing (TEG\/ROTEM) in obstetrics and recommendations from the women\u2019s SSC of the ISTH","volume":"18","author":"Amgalan","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1160\/TH08-06-0386","article-title":"Coagulation assessment by rotation thrombelastometry in normal pregnancy","volume":"101","author":"Huissoud","year":"2009","journal-title":"Thromb. Haemost."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/hematology.2020000139","article-title":"Prevention and treatment of postpartum hemorrhage: Focus on hematological aspects of management","volume":"2020","author":"McLintock","year":"2020","journal-title":"Hematology"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/27\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:52:35Z","timestamp":1766393555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jcm15010027"],"URL":"https:\/\/doi.org\/10.3390\/jcm15010027","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]}}}